Ligand Pharmaceuticals Inc (LGND)
EBITDA Margin
94.32%
TTM · Period ending:
LGND EBITDA Margin
Latest reported94.32%period ending
Latest reported94.32%period ending
LGND TTM EBITDA Margin (-138.35% → 94.32%)
TTM ebitda margin
High-resolution chart · PNG
LGND ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -63.4376% | |
| -78.3637% | |
| -88.0646% | |
| -89.5694% | |
| -95.4659% | |
| -109.9293% | |
| -119.6455% | |
| -169.6189% | |
| -221.9331% | |
| -265.0655% | |
| -349.7175% | |
| -112.2159% | |
| -77.5904% | |
| -52.9787% | |
| -40.4255% | |
| -75.443% | |
| -61.9289% | |
| -65.7895% | |
| -62.7027% | |
| -60.3399% | |
| -80.8176% | |
| -43.9024% | |
| -44.898% | |
| -38.3178% | |
| -31.3514% | |
| -106.4103% | |
| -138.3459% |